NO178734C - Fremgangsmåte for fremstilling av en ny arginin-deiminase - Google Patents

Fremgangsmåte for fremstilling av en ny arginin-deiminase

Info

Publication number
NO178734C
NO178734C NO903398A NO903398A NO178734C NO 178734 C NO178734 C NO 178734C NO 903398 A NO903398 A NO 903398A NO 903398 A NO903398 A NO 903398A NO 178734 C NO178734 C NO 178734C
Authority
NO
Norway
Prior art keywords
preparing
arginine deiminase
mycoplasma
new arginine
enzyme
Prior art date
Application number
NO903398A
Other languages
English (en)
Norwegian (no)
Other versions
NO178734B (no
NO903398L (no
NO903398D0 (no
Inventor
Haruo Takaku
Kaoru Miyazaki
Miho Aoshima
Original Assignee
Japan Energy Corp
Nikko Kyodo Company
Nippon Mining Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Japan Energy Corp, Nikko Kyodo Company, Nippon Mining Co Ltd filed Critical Japan Energy Corp
Publication of NO903398D0 publication Critical patent/NO903398D0/no
Publication of NO903398L publication Critical patent/NO903398L/no
Publication of NO178734B publication Critical patent/NO178734B/no
Publication of NO178734C publication Critical patent/NO178734C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/78—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO903398A 1989-08-02 1990-08-01 Fremgangsmåte for fremstilling av en ny arginin-deiminase NO178734C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP20090289 1989-08-02

Publications (4)

Publication Number Publication Date
NO903398D0 NO903398D0 (no) 1990-08-01
NO903398L NO903398L (no) 1991-02-04
NO178734B NO178734B (no) 1996-02-12
NO178734C true NO178734C (no) 1996-05-22

Family

ID=16432163

Family Applications (1)

Application Number Title Priority Date Filing Date
NO903398A NO178734C (no) 1989-08-02 1990-08-01 Fremgangsmåte for fremstilling av en ny arginin-deiminase

Country Status (12)

Country Link
US (1) US5474928A (fr)
EP (1) EP0414007B1 (fr)
JP (1) JP2900279B2 (fr)
AT (1) ATE125295T1 (fr)
CA (1) CA2022177C (fr)
DE (1) DE69020979T2 (fr)
DK (1) DK0414007T3 (fr)
ES (1) ES2078277T3 (fr)
FI (1) FI903826A0 (fr)
IE (1) IE62120B1 (fr)
NO (1) NO178734C (fr)
PT (1) PT94882B (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0956864A1 (fr) * 1996-12-03 1999-11-17 Kyowa Hakko Kogyo Co., Ltd. Inhibiteur de fibrose des tissus
US5804183A (en) * 1997-01-31 1998-09-08 Enzon, Inc. Arginine deminase derived from mycoplasma arthritidis and polymer conjugates containing the same
US6635462B1 (en) * 1997-05-12 2003-10-21 Phoenix Pharmacologies, Inc. Mutated form of arginine deiminase
US6183738B1 (en) 1997-05-12 2001-02-06 Phoenix Pharamacologics, Inc. Modified arginine deiminase
US6180387B1 (en) 1997-08-11 2001-01-30 Smithkline Beecham Corporation Arginine deiminase
IT1298918B1 (it) 1998-02-20 2000-02-07 Mendes Srl Uso di batteri dotati di arginina deiminasi per indurre apoptosi e/o ridurre una reazione infiammatoria e composizioni farmaceutiche
WO2002009741A1 (fr) * 2000-07-27 2002-02-07 Angiolab, Inc. Composition pharmaceutique comprenant une arginine deiminase destinee a inhiber l'angiogenese
EP1599217B1 (fr) * 2002-11-18 2014-04-16 Polaris Group Methodes d'inhibition d'une replication virale in vivo
FR2884717B1 (fr) 2005-04-25 2009-07-03 Erytech Pharma Soc Par Actions Erythrocytes renfermant de l'arginine deiminase
CN101002945B (zh) 2006-01-20 2012-09-05 清华大学 一种用于肿瘤治疗的新型复合物
FR2919804B1 (fr) 2007-08-08 2010-08-27 Erytech Pharma Composition et vaccin therapeutique anti-tumoral
EP2295560A1 (fr) 2009-09-14 2011-03-16 RWTH Aachen University Évolution dirigée de l'arginine déiminase pour une activité accrue à un pH physiologique
US9255262B2 (en) * 2013-03-06 2016-02-09 Vision Global Holdings Ltd. Albumin-binding arginine deminase and the use thereof
USRE48805E1 (en) 2013-03-06 2021-11-02 Vision Global Holdings Ltd. Method for cancer targeting treatment and detection of arginine using albumin-binding arginine deiminase fusion protein
ES2805360T3 (es) 2013-03-15 2021-02-11 Tdw Group Arginina desiminasa con reactividad cruzada reducida hacia anticuerpos para ADI - PEG 20 para el tratamiento del cáncer
KR102353046B1 (ko) 2014-03-18 2022-01-19 티디더블유 그룹 조작된 키메라성 페길화된 ａｄｉ 및 사용 방법
WO2017041051A1 (fr) 2015-09-04 2017-03-09 Sqz Biotechnologies Company Administration intracellulaire de biomolécules à des cellules comprenant une paroi cellulaire
WO2019042628A1 (fr) 2017-08-31 2019-03-07 Erytech Pharma Arginine déiminase encapsulée à l'intérieur d'érythrocytes et leur utilisation dans le traitement du cancer et d'une déficience en arginase-1
EP3449935A1 (fr) 2017-08-31 2019-03-06 Erytech Pharma Arginine deiminase encapsulée à l'intérieur des érythrocytes et leur utilisation dans le traitement du cancer et de la déficience en arginase-1

Also Published As

Publication number Publication date
EP0414007A3 (en) 1991-03-20
DE69020979D1 (de) 1995-08-24
CA2022177A1 (fr) 1991-02-03
ES2078277T3 (es) 1995-12-16
NO178734B (no) 1996-02-12
FI903826A0 (fi) 1990-08-01
DK0414007T3 (da) 1995-09-04
EP0414007A2 (fr) 1991-02-27
IE62120B1 (en) 1994-12-14
PT94882A (pt) 1991-05-22
PT94882B (pt) 1997-07-31
JPH03164173A (ja) 1991-07-16
IE902771A1 (en) 1991-02-27
JP2900279B2 (ja) 1999-06-02
EP0414007B1 (fr) 1995-07-19
DE69020979T2 (de) 1996-01-04
ATE125295T1 (de) 1995-08-15
CA2022177C (fr) 2001-02-27
NO903398L (no) 1991-02-04
NO903398D0 (no) 1990-08-01
US5474928A (en) 1995-12-12

Similar Documents

Publication Publication Date Title
NO178734C (no) Fremgangsmåte for fremstilling av en ny arginin-deiminase
EP0386757A3 (en) Biodegradable poly (phosphate esters)
BR9910251A (pt) Estimulação hematopoiética
FI906438A0 (fi) Menetelmä uusien, terapeuttisesti käyttökelpoisten A-nor-steroidi-3-karboksyylihappojohdannaisten valmistamiseksi
PL292738A1 (en) Method of obtaining novel derivatives of dihydroisoquinoline
DE60110106D1 (de) Verfahren zur herstellung von pankreasenzym enthaltende mikrosphären mit hoher stabilität
DE69302508D1 (de) Taxanderivate, ihre Herstellung und ihre Anwendung in der Onkologie
IT8920063A0 (it) Metodi per la preparazione di composizioni farmaceutiche a base di bromocriptina dotate di elevata stabilita' e prodotti derivanti.
NO179612C (no) Analogifremgangsmåte for fremstilling av 3-arylkarbonyl-1-aminoalkyl-1H-indol-forbindelser
IT8919972A0 (it) Processo per la produzione di articoli formati di grandi dimensioni, costituiti da poliammide modificata.
DZ1407A1 (fr) Dérivés d-substitués des n,n'-ditriméthoxybenzoylepipérazine ainsi que leur procédé de préparation.
DE3863136D1 (de) Derivate des 2,2-bis-(3-aminophenyl)-hexafluorpropans und verfahren zur herstellung des 2,2-bis-(3,4-diaminophenyl)-hexafluorpropans.
FR2708938B1 (fr) Procédé enzymatique perfectionné de préparation d'oligomères de L-lysine.
NO874404D0 (no) Fremgangsmaate for fremstilling av acyleringsprodukter av bis (2-imidazolin-2-ylhydrazoner) av 9,10-antracendikarboksaldehyd.
NO950952L (no) Fremgangsmåte for fremstilling av pilokarpin
DE59907422D1 (de) N,N'-disubstituierte N-(2-hydroxyalkyl)-Harnstoffe
IT8919503A0 (it) Processo per la preparazione di eparina e glicosaminoglicani ad elevata attivita' e privi di impurezze potenziali.
GR3020597T3 (en) Phospholipids for the treatment of multiple sclerosis
Kim et al. Effect of Nitrogen Split Application on Dry Matter Production and of Rice Transplanted by Machine
FR2698874B1 (fr) Procédé de préparation de dérivés d'acétoamides, d'acétothioamides et d'acétosélénoamides, en particulier de dérivés de carbamoylméthylphosphines et carbamoylméthylphosphines ainsi obtenues.
IT1233569B (it) Macchina per la produzione di neve con convogliamento anulare dell'aria.
ATE83767T1 (de) Verfahren zur herstellung von 4,4' diaminodiphenylmethan und derivaten davon.
BR8805094A (pt) Processo para obtencao de 5-hidroxi-3,6,7,3',4'-pentemetoxiflavona,produto obtido e utilizacao do mesmo
IT9003363A0 (it) Metodo per la fabbricazione di calzature,in particolare con il fondo acuscino d'aria,e calzatura ottenuta con tale metodo
IT1213033B (it) Esteri di n-alchil-nortropine eloro derivati ammonioquaternari aventi attivita'anti-broncospastica, procedimento per la loro preparazione e composizioni farmaceutiche che licontengono.